Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-22 Sale | 2023-06-23 5:36 pm | DICE Therapeutics Inc. | DICE | Northpond Ventures GP LLC Northpond Ventures LP Northpond Ventures GP II LLC Northpond Ventures II LP Rubin Michael P. 10% Owner | 2,492,871 | $46.5 | $115,918,502 | 166,293 (Indirect) | View |
| 2023-06-01 Sale | 2023-06-02 8:11 pm | DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO | 18,750 | $30.53 | $572,444 | 147,497 (Direct) | View |
| 2023-05-05 Sale | 2023-05-09 6:02 pm | DICE Therapeutics Inc. | DICE | SCHELLER RICHARD H Director | 84,097 | $38.51 | $3,238,205 | 8,427 (Direct) | View |
| 2023-05-03 Sale | 2023-05-05 5:19 pm | DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO | 18,750 | $36.55 | $685,350 | 198,000 (Direct) | View |
| 2023-05-03 Sale | 2023-05-05 5:10 pm | DICE Therapeutics Inc. | DICE | Timothy Lu CMO | 10,000 | $36.54 | $365,398 | 152,285 (Direct) | View |
| 2023-05-03 Sale | 2023-05-05 5:03 pm | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 13,698 | $36.5 | $499,977 | 799,685 (Direct) | View |
| 2023-04-18 Sale | 2023-04-19 7:28 pm | DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO | 16,392 | $30.08 | $493,127 | 166,247 (Direct) | View |
| 2023-03-31 Sale | 2023-04-04 5:31 pm | DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO | 773 | $30 | $23,190 | 182,639 (Direct) | View |
| 2023-03-28 Purchase | 2023-03-30 5:03 pm | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 509,145 | $29.07 | $14,798,693 | 7,856,612 (Indirect) | View |
| 2023-03-28 Sale | 2023-03-30 4:35 pm | DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO | 1,594 | $30.03 | $47,867 | 183,412 (Direct) | View |
| 2023-03-23 Purchase | 2023-03-27 5:01 pm | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 498,556 | $26.99 | $13,457,372 | 7,347,467 (Indirect) | View |
| 2023-03-17 Sale | 2023-03-21 4:47 pm | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 10,000 | $29.05 | $290,500 | 45,841 (Indirect Direct) | View |
| 2022-10-17 Purchase | 2022-10-19 4:32 pm | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 1,640,000 | $36.5 | $59,860,000 | 6,848,911 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-08-09 Disposition | 2023-08-09 5:00 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Former 10% owners and Director Director | 21,250 | $0 | 0 (Indirect) | View |
| 2023-08-09 Equity Swap | 2023-08-09 5:00 pm | N/A N/A | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Former 10% owners and Director Director | 7,856,612 | $0 | 0 (Indirect) | View |
| 2023-08-09 Disposition | 2023-08-09 4:38 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | TETLOW SHARON Director | 105,248 | $0 | 0 (Direct) | View |
| 2023-08-09 Disposition | 2023-08-09 4:36 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | Simson Jake Director | 21,250 | $0 | 0 (Direct) | View |
| 2023-08-09 Disposition | 2023-08-09 4:33 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 96,328 | $0 | 0 (Direct) | View |
| 2023-08-09 Disposition | 2023-08-09 4:31 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO | 612,511 | $0 | 0 (Direct) | View |
| 2023-08-09 Disposition | 2023-08-09 4:29 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | SCHELLER RICHARD H Director | 84,033 | $0 | 0 (Direct) | View |
| 2023-08-09 Disposition | 2023-08-09 4:26 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | Timothy Lu CMO | 515,105 | $0 | 0 (Direct) | View |
| 2023-08-09 Disposition | 2023-08-09 4:25 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 1,834,811 | $0 | 0 (Direct) | View |
| 2023-08-09 Disposition | 2023-08-09 4:23 pm | N/A 2031-09-14 | DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO | 502,603 | $0 | 0 (Direct) | View |
| 2023-08-09 Disposition | 2023-08-09 4:21 pm | N/A 2032-03-31 | DICE Therapeutics Inc. | DICE | Doyle Mittie Director | 42,500 | $0 | 0 (Direct) | View |
| 2023-08-09 Disposition | 2023-08-09 4:19 pm | N/A 2032-03-31 | DICE Therapeutics Inc. | DICE | Bowers Lisa Director | 42,500 | $0 | 0 (Direct) | View |
| 2023-08-02 Gift | 2023-08-03 7:37 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 2,420 | $0 | 40,921 (Indirect) | View |
| 2023-07-18 Gift | 2023-07-19 4:53 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 2,200 | $0 | 43,341 (Indirect) | View |
| 2023-07-11 Gift | 2023-07-13 5:12 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 300 | $0 | 45,541 (Indirect) | View |
| 2023-05-01 Gift | 2023-05-02 5:49 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 6,923 | $0 | 45,841 (Direct) | View |
| 2022-10-24 Gift | 2023-03-21 4:47 pm | N/A N/A | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 30,719 | $0 | 45,841 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 5:44 pm | N/A 2033-01-26 | DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO | 131,250 | $0 | 131,250 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 5:37 pm | N/A 2033-01-26 | DICE Therapeutics Inc. | DICE | Timothy Lu CMO | 105,000 | $0 | 105,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 5:30 pm | N/A 2033-01-26 | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 350,000 | $0 | 350,000 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 5:25 pm | N/A 2033-01-26 | DICE Therapeutics Inc. | DICE | Jacobsen John R. CSO | 105,000 | $0 | 105,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 5:30 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 21,250 | $0 | 21,250 (Indirect) | View |
| 2022-06-07 Option Award | 2022-06-08 5:06 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | TETLOW SHARON Director | 21,250 | $0 | 21,250 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 5:01 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | Simson Jake Director | 21,250 | $0 | 21,250 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:53 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | Scopa James Paul Director | 21,250 | $0 | 21,250 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 4:48 pm | N/A 2032-06-06 | DICE Therapeutics Inc. | DICE | SCHELLER RICHARD H Director | 31,250 | $0 | 31,250 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-19 7:05 pm | N/A 2032-04-14 | DICE Therapeutics Inc. | DICE | Robertson Scott M. CFO & CBO | 154,250 | $0 | 154,250 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-19 7:00 pm | N/A 2032-04-14 | DICE Therapeutics Inc. | DICE | Timothy Lu CMO | 157,756 | $0 | 157,756 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-19 6:52 pm | N/A 2032-04-14 | DICE Therapeutics Inc. | DICE | Judice Kevin CEO | 384,900 | $0 | 384,900 (Direct) | View |